More Evidence Backs Gout Benefit for Gliflozin Agents

(MedPage Today) -- MILAN -- Canadian patients taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes saw reductions in rates of incident gout, ranging from about 40% to 60% relative to three other classes typically added...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news